The 2nd European Cancer and Oncology Congress, scheduled for November 03–04, 2025 in Prague, Czech Republic, will be a premier forum for advancing cancer science and clinical care. Designed to foster collaboration and innovation, the event will convene oncologists, scientists, healthcare professionals, nurses, and researchers from across Europe and beyond to exchange knowledge, discuss new findings, and spotlight transformative developments in oncology.
Attendees can look forward to a rich and engaging program featuring high-impact keynote sessions from world-renowned experts, thought-provoking symposia, interactive workshops, and research poster showcases. The congress will delve into critical areas including precision oncology, immunotherapy, emerging treatment strategies, survivorship, palliative and supportive care, and the integration of digital tools and AI into oncology practice. Set against the stunning backdrop of Prague, this event offers an inspiring environment to connect, learn, and drive progress in cancer care.
Abstract Submission Deadline: June 16, 2025
Early Bird Registration: June 18, 2025
Mid Term Registration: August 29, 2025
Final/Onsite Registration: Nov 3, 2025
GermanOncology
Germany
Goethe University Frankfurt
Germany
251 Airforce General Hospital
Greece
National Center of Oncology
Azerbaijan
European Institute of Oncology
Italy
Lebanese Society of Medical Oncology
Lebanon
National Center for Cancer Care and Research
Qatar
Azienda Ospedaliera di Rilevanza Nazionale Antonio Cardarelli
Italy
GermanOncology
Germany
Brigham and Women’s Hospital & Harvard Medical School
USA
University Medical Center Hamburg-Eppendorf (UKE)
Germany
Dear Colleagues
As an Organizing Committee Member of the European Cancer and Oncology Congress, it is my pleasure and honor to invite you to join us in Prague, Czech Republic, on 03-04 November, 2025. This congress aims to gather leading experts and researchers to discuss the latest advancements in cancer and oncology.
The congress will focus on cutting-edge developments and innovative approaches in the field, providing valuable insights for scientists, researchers, clinicians, and healthcare professionals. Cancer is a field that unites all of us from the subscellular level to the therapeutic algorithm. So it is an opportunity to fuse our energies into a collaboration and into a synthesis of views, clinical pratices and concerns.
We look forward to welcoming you your research team, and your colleagues to this impactful event in Prague.
Best Wishes,
Folinas Konstantinos
251 Airforce General Hospital, Athens, Greece
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative; 2018-2022), and Dimensions (Digital Science).
Scope
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural editorial, Introducing Oncotarget
C2P Forum is pleased to announce the successful completion of the European Congress on Cancer and Oncology, held on April 14-15, 2025, in Rome, Italy.
The conference, themed “Innovations in Cancer and Oncology: From Research to Patient Care,” concluded with great success.
We extend our sincere gratitude to the esteemed scientists, distinguished researchers, students and professionals from universities, research institutions, companies, and laboratories worldwide who contributed their latest insights and expertise in the field of Cancer and Oncology.
The conference featured a dynamic program, including keynote addresses, oral presentations, poster sessions, and video presentations. The event was marked by significant engagement and outstanding contributions, and we are delighted to share some of the key highlights presented during the sessions:
We would like to express our sincere appreciation to our Session Chairs Thomas Licht, Ludwig Boltzmann for Rehabilitation Research, Austria, Stuart S. Martin, University of Maryland School of Medicine, USA.
Building on the success of the Cancer 2025, we are pleased to announce our upcoming event, 2nd European Meeting on Cancer and Oncology on November 03-04, 2025, in Prague, Czech Republic.
More info: https://cancer.c2pforum.com/
Huge thanks to all the delegates! Your energy and involvement made this event a big success!
Mark your calendars and set your reminders.
Hope to meet you again in Prague, Czech Republic!!